-- BioTech-Europe, Diatech, Labgene Scientific, and Neo-Science embrace company’s award-winning droplet technology platform to meet growing demand for liquid biopsy research applications --
BILLERICA, Mass. — April 16, 2015 — RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced agreements with BioTech-Europe, Diatech Pharmacogenetics srl, Labgene Scientific, and Neo-Science & Group, enabling these companies to distribute RainDance products in Central and Eastern Europe, Italy, Switzerland, the Kingdom of Bahrain, State of Kuwait, Sultanate of Oman, State of Qatar, Kingdom of Saudi Arabia, and State of the United Arab Emirates. These agreements are the latest components of RainDance’s channel and expansion strategy to meet the growing demand for liquid biopsy applications outside the United States.
“New, non-invasive liquid biopsy research applications will fundamentally improve the way scientists examine biomarkers in cancer and other complex inherited disorders or infectious diseases,” said Oliva Alberti, CEO, Diatech Pharmacogenetics srl. “Because of its ability to perform true single molecule PCR in droplets, RainDance is capable of delivering the required sensitivity, precision and accuracy needed to examine cell-free circulating DNA that is often fragmented and only available in low quantities.”
“RainDance features a compelling portfolio of ultra-sensitive genetic analysis products based on the core digital droplet technology platform,” stated Gilles Erba, Technical Director at Labgene Scientific SA. “RainDance’s products fit perfectly within our comprehensive molecular biology product portfolio, and will unlock a number of new business opportunities and research applications across Switzerland.”
Complex Genetics Made Simple
RainDance Technologies offers an innovative product portfolio to research cell-free and cell-based biomarkers for hereditary risk predisposition, pathology and progression, and residual disease monitoring. The company’s research use only products include:
RainDrop® Digital PCR System: Ultra-sensitive digital PCR system for research of early detection and monitoring of cell-free and cell-based biomarkers for cancers, viruses, pathogens, and immune disorders.
ThunderBolts™ NGS Enrichment System: New ‘Democratized’ targeted NGS system enabling highly sensitive, rapid, low input, profiling of solid tumors and hematological cancer research in plasma, tissue and FFPE samples.
ThunderStorm® NGS Enrichment System: Industrial-scale workhorse for highly accurate, fully-automated targeted NGS enrichment.
“The teams at BioTech-Europe, Labgene, Diatech, and Neo Science bring decades of industry experience and represent what we look for in a distributor,” said Sandy McBean, Director of European Sales at RainDance Technologies. “We are starting to see acceleration in the adoption of our products across Europe and the Middle East as more researchers look to pursue non-invasive liquid biopsy research for more accurate, reliable, cost-effective, and early detection of cancer and other complex diseases.”
Over the past two years RainDance has strengthened its European commercial staff with the addition of Sandy McBean, field sales representatives, applications support and service staff, as well as a similar distribution agreement with BIOKÉ, a Cell Signaling Technology Europe (CST Europe) company for The Netherlands, Belgium and Luxembourg.
BioTech-Europe is a leading supplier of high tech innovative life-science technologies in the territory of Central and Eastern Europe. Based in the Czech Republic, the company provides sales and marketing services and technical and application support in the following countries: Slovakia, Hungary, Poland, Croatia, Slovenia, Serbia, Romania, Bulgaria, Latvia, Lithuania, Estonia, Russia, Ukraine, Belarus, and Turkey. For more information, please visit: www.biotech-europe.eu.
About Diatech Pharmacogenetics
Diatech Pharmacogenetics is the unique diagnostic company in Italy focusing its research efforts on pharmacogenetics. The company supports its own research efforts commercializing and developing pharmacogenetic tests for personalized and predictive medicine, especially relating to anti-cancer and genetic disease treatments and therapies. For more information, please visit: www.diatechpharmacogenetics.com/.
About Labgene Scientific SA
Labgene Scientific SA has been commercializing advanced and high quality products, reagents and consumables for molecular biology laboratories, facilities and platforms for more than 20 years. They provide integrated solutions for life science research, diagnostic laboratories and the pharmaceutical industry. For additional information please visit: www.labgene.ch.
About Neo-Science & Group
Neo-Science and Group is a trusted provider of high quality solutions and services to the Life Science research and Clinical Diagnostics. Neo-Science is incorporated by founding member and CEO Nadia Abu Hijleh. Headquartered in Dubai, the group operates effectively across the UAE, Kingdom of Saudi Arabia, Qatar, Kuwait, Bahrain Oman and other Middle East Countries. Neo-Science consolidates, Neoscience Saudi (GSL), Neoscience Qatar (QSC), and Neoscience Kuwait (KSC). Neo-Science employs around 100 qualified professionals and has acquired a solid reputation for delivering innovative products integrated solutions and professional support across Life Science, Diagnostics, Analytical and Informatics. For more information, please visit: www.neosciencegroup.com.